Stay updated on SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.

Latest updates to the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.7%
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check63 days agoChange DetectedThe page has removed a significant study reference regarding Pomalidomide and low-dose dexamethasone in multiple myeloma, which is a core aspect of the content.SummaryDifference0.1%
- Check70 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.